rs515726146
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_015474.4(SAMHD1):c.649_650insG(p.Phe217CysfsTer2) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000031 in 1,613,984 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_015474.4 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SAMHD1 | NM_015474.4 | c.649_650insG | p.Phe217CysfsTer2 | frameshift_variant | Exon 6 of 16 | ENST00000646673.2 | NP_056289.2 | |
SAMHD1 | NM_001363729.2 | c.649_650insG | p.Phe217CysfsTer2 | frameshift_variant | Exon 6 of 15 | NP_001350658.1 | ||
SAMHD1 | NM_001363733.2 | c.649_650insG | p.Phe217CysfsTer2 | frameshift_variant | Exon 6 of 16 | NP_001350662.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152146Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251460Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135902
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461838Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 727224
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152146Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74330
ClinVar
Submissions by phenotype
Aicardi-Goutieres syndrome 5 Pathogenic:2Other:1
This sequence change creates a premature translational stop signal (p.Phe217Cysfs*2) in the SAMHD1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SAMHD1 are known to be pathogenic (PMID: 19525956, 22461318). This variant is present in population databases (no rsID available, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with Aicardi-Goutieres syndrome (PMID: 20653736). ClinVar contains an entry for this variant (Variation ID: 126413). For these reasons, this variant has been classified as Pathogenic. -
The SAMHD1 c.649_650insG (p.Phe217CysfsTer2) variant results in the insertion of a nucleotide at position c.649, causing a shift in the protein reading frame that is predicted to result in premature termination of the protein. Loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay is expected. The variant has been reported in a compound heterozygous state with a known pathogenic deletion in one individual with Aicardi-Goutieres syndrome (PMID: 20653736). This variant is reported in the Genome Aggregation Database in one allele at a frequency of 0.000325 in the Ashkenazi Jewish population (version 3.1.2). The c.649_650insG variant lies in the HD domain of the protein which is reported to be involved in nucleotide binding (PMID: 22461318). Based on the available evidence, the c.649_650insG (p.Phe217CysfsTer2) variant is classified as pathogenic for Aicardi-Goutieres syndrome. -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at